Skip to main content

Invus — Portfolio, Page 3

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

117
Companies
$9.5B
Total invested
$93.6M
Avg. check
54
Industries
Health Care 12Biotechnology 11Information Technology 7Therapeutics 7Medical 6Software 4+48 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 49–72 of 117
Inotrem
November 2023

Inotrem is a biotechnology company specialized in immunotherapy for acute inflammatory syndromes, such as septic shock.

Biotechnology · ParisVenture - Series Unknown
Health Data Analytics Institute
October 2023

HDAI is an health care analytics company with a platform that creates a shared understanding of health risks and personalized care profiles.

Analytics · Dedham$31.0M Series C
Finastra
August 2023

Finastra provides the broadest portfolio of financial services software.

Financial Services · Paddington$5.3B Debt Financing
Tisento Therapeutics
July 2023

Tisento Therapeutics is a MA-based developer of novel medicines to treat diseases with significant unmet medical needs.

Health Care · Cambridge$81.0M Series A
Presidio Medical
June 2023

Presidio Medical is a medtech company that develops a transformational neuromodulation platform.

Developer Platform · South San Francisco$72.0M Series C
Cyclerion Therapeutics
May 2023

Cyclerion Therapeutics harnesses the potential of soluble guanylate cyclase (sGC) pharmacology.

Biotechnology · Cambridge$5.0M Post-IPO Equity
Ikena Oncology
May 2023

Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.

Biotechnology · Boston$40.0M Post-IPO Equity
Morphic Therapeutic
May 2023

Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.

Biotechnology · Waltham$276.0M Post-IPO Equity
Flare Therapeutics
March 2023

Flare Therapeutics is a biotech startup that creates precision therapies for cancer and other disorders by targeting transcription factors.

Biopharma · Cambridge$123.0M Series B
Ring Therapeutics
March 2023

Ring Therapeutics is a gene therapy company focused on discovering and developing programmable genetic medicines.

Biotechnology · Cambridge$86.5M Series C
Belliwelli
January 2023

Belliwelli offers four gut-friendly, plant-based snack bars that caters to people with IBS.

Food and Beverage · Los Angeles$15.4M Series A
Valo Health
October 2022

Valo Health is a technology company focused on utilizing large scale data and AI-driven computation to discover and develop therapeutics.

Biotechnology · BostonSeries C
HappyVore
June 2022

HappyVore cultivates a passion for taste, the real, the healthy, and the impact on the planet.

Agriculture · Paris$36.9M Venture - Series Unknown
Learn In
March 2022

Learn In is an upskilling-as-a-service platform that connects employers and learners.

EdTech · San Francisco$10.0M Series A
Marlette Funding
March 2022

Marlette Funding is a financial tech company tasked to empower customers.

Financial Services · Wilmington$225.0M Series E
TigerConnect
January 2022

TigerConnect is a healthcare collaboration platform that streamlines clinical workflows and systems.

Collaboration · Santa Monica$300.0M Private Equity
Evenly Technologies, Inc.
January 2022

Evenly is a technology and telemedicine platform that enables general dentists to provide orthodontics in their practice.

Dental · WashingtonSeed
Laronde
August 2021

Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.

Biotechnology · Cambridge$440.0M Series B
FireHydrant
August 2021

FireHydrant is an incident management tool that helps companies recover from IT disasters more quickly.

Data Center Automation · New York$23.0M Series B
Foghorn Therapeutics
January 2026

Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,

Biopharma · Cambridge$50.0M Post Ipo Equity
Rapido
January 2026

Rapido provides a platform for booking bike taxis, autos, and cabs.

Information Services · BangaloreSecondary Market
Triana Biomedicines
December 2025

Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.

Biopharma · Lexington$120.0M Series B
Ablative Solutions
November 2025

Ablative Solutions is a medical device firm that offers an alternative to surgical renal denervation for treating hypertension.

Biotechnology · Wakefield$10.4M Series Unknown
Aive
November 2025

Aive is a technology company that provides an AI-driven video post-production platform as software-as-a-service.

Artificial Intelligence (AI) · Levallois-perret$5.2M Series A

Where Invus invests

Health Care12
Biotechnology11
Information Technology7
Therapeutics7
Medical6
Software4

About Invus's portfolio

How many companies has Invus invested in?▸

Invus has invested in 117 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Invus invest in?▸

Invus's top investment sectors include Health Care, Biotechnology, Information Technology, Therapeutics, Medical. The firm invests across 54 different industry categories.

What is Invus's largest investment?▸

Among tracked funding rounds, Finastra received $5.3B in a Debt Financing round. Invus's total known invested capital is $9.5B.

What is the average investment size for Invus?▸

Invus's average investment size is $93.6M across its portfolio of 117 companies.

What are Invus's most recent investments?▸

Recent Invus portfolio additions include Inotrem, Health Data Analytics Institute, Finastra, Tisento Therapeutics, Presidio Medical. These companies were founded in 2020 or later.

Reach the founders behind these 117 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →